Signaturefd, LLC Mesoblast LTD Transaction History

Signaturefd, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$1.22 - $4.83 $11,054 - $43,764	-9,061 Reduced 83.47%	1,794 $2,000
Q2 2023 Aug 01, 2023	BUY	$2.95 - $4.44 $21,328 - $32,101	7,230 Added 199.45%	10,855 $42,000
Q1 2023 Apr 28, 2023	BUY	$2.94 - $4.18 $11 - $16	4 Added 0.11%	3,625 $11,000
Q4 2022 Jan 27, 2023	BUY	$2.73 - $3.7 $8,970 - $12,158	3,286 Added 980.9%	3,621 $10,000
Q3 2022 Nov 08, 2022	BUY	$0.48 - $3.48 $160 - $1,165	335 New	335 $1,000
Q2 2022 Aug 10, 2022	SELL	$2.22 - $4.54 $1,627 - $3,327	-733 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$3.58 - $4.98 $397 - $552	-111 Reduced 13.15%	733 $3,000
Q4 2021 Jan 25, 2022	SELL	$4.17 - $7.09 $2,764 - $4,700	-663 Reduced 43.99%	844 $4,000
Q3 2021 Oct 28, 2021	BUY	$5.87 - $7.85 $8,106 - $10,840	1,381 Added 1096.03%	1,507 $9,000
Q2 2021 Jul 26, 2021	BUY	$6.69 - $9.0 $394 - $531	59 Added 88.06%	126 $1,000
Q1 2021 Apr 30, 2021	BUY	$8.26 - $11.4 $553 - $763	67 New	67 $1,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.2B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.